These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 12858325)
21. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. Zanardi R; Franchini L; Serretti A; Perez J; Smeraldi E J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642 [TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Stahl SM; Entsuah R; Rudolph RL Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062 [TBL] [Abstract][Full Text] [Related]
23. Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K; Perry CM CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036 [TBL] [Abstract][Full Text] [Related]
24. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group. Haffmans PM; Timmerman L; Hoogduin CA Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. Silverstone PH; Salinas E J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362 [TBL] [Abstract][Full Text] [Related]
27. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group. Wheatley DP; van Moffaert M; Timmerman L; Kremer CM J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343 [TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. Schmidt ME; Fava M; Robinson JM; Judge R J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738 [TBL] [Abstract][Full Text] [Related]
29. A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up. Findling RL; McCusker E; Strawn JR J Child Adolesc Psychopharmacol; 2020 Jul; 30(6):355-365. PubMed ID: 32460523 [No Abstract] [Full Text] [Related]
30. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition. Ushiroyama T; Ikeda A; Ueki M J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873 [TBL] [Abstract][Full Text] [Related]
31. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. Barbosa L; Berk M; Vorster M J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240 [TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Schatzberg A; Roose S Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045 [TBL] [Abstract][Full Text] [Related]
33. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P Am J Psychiatry; 2004 Nov; 161(11):2060-5. PubMed ID: 15514407 [TBL] [Abstract][Full Text] [Related]
34. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835 [TBL] [Abstract][Full Text] [Related]
35. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode]. Ontiveros-Sánchez de la Barquera JA Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826 [TBL] [Abstract][Full Text] [Related]
36. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Muijsers RB; Plosker GL; Noble S Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324 [TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320 [TBL] [Abstract][Full Text] [Related]
38. [Fluoxetine versus fluvoxamine for treatment of chronic pain]. Ciaramella A; Grosso S; Poli P Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983 [TBL] [Abstract][Full Text] [Related]
39. Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder. Nemets B; Bersudsky Y; Belmaker RH J Clin Psychiatry; 2005 May; 66(5):586-90. PubMed ID: 15889944 [TBL] [Abstract][Full Text] [Related]
40. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies. Feiger AD; Flament MF; Boyer P; Gillespie JA Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]